Neurowave Medical Technologies (NMT) is committed to being the leader in the development of transdermal neuromodulation devices for various acute and chronic conditions of the central nervous system (CNS) and gastrointestinal (GI) tract.
Our goal is to use our robust proprietary technology platform to develop innovative non-invasive transdermal medical devices that can treat acute and chronic clinical conditions by complementing or replacing current pharmaceutical treatments for those same diseases.
NMT is pursuing multiple other indications in numerous CNS based disease states that are well-suited to this unique delivery platform.
